Although this sample of tumours is small, these data suggest individual PCa patients have heterogeneous patterns of PTPRR expression relative to other potential modifier genes (Figure 4C, western blot with patient information shown below), and might contribute to the known heterogeneity of prostate tumours. Here, PTPRR is linked to prostate neoplasm.